Launch week offerEnds in00h00m00s

annual Promonthly Pro

Carlos Taxonera

Senior staff, Head IBD Unit

Hospital Clínico San Carlos

Spain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Spain

About

Dr. Carlos Taxonera is a Senior Staff and Head of the IBD Unit at Hospital Clínico Universitario San Carlos, Spain. His research primarily focuses on the effectiveness and safety of treatments for inflammatory bowel disease, particularly ulcerative colitis and Crohn's disease. Recent articles have explored topics such as the effects of biologics like golimumab and upadacitinib, as well as biomarkers related to disease progression. He is committed to improving patient outcomes through rigorous clinical research and analysis.

Articles (14)

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (11)

Alba Angelina

Assistant Professor

Universidad Complutense de Madrid

SPAIN

View details

Javier Pérez Gisbert

Principal Investigator

Universidad Autónoma de Madrid

SPAIN

View details

Cristina Benito-Villalvilla

Assistant Proffesor

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

ALEJANDRO HERNANDEZ CAMBA

Profesor Colaborador

SPAIN

View details

Inmaculada Alonso Abreu

F.E.A. de Aparato Digestivo

Hospital Universitario de Canarias

SPAIN

View details

Luis Bujanda

University of the Basque Country/Euskal Herriko Unibertsitatea (UPV/EHU)

SPAIN

View details

Beatriz Pereira

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto

PORTUGAL

View details

Angel Ponferrada

Profesor Asociado

Universidad Complutense de Madrid

SPAIN

View details

Laura Ramos López

Médico Adjunto

Hospital Universitario de Canarias

SPAIN

View details

FRANCISCO RODRIGUEZ MORANTA

Bellvitge University Hospital

SPAIN

View details

Leticia Martín-Cruz

Assistant Proffesor

Universidad Complutense de Madrid Facultad de Medicina

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carlos Taxonera

Research Interests

Make your next move.

Explore related searches

About

Articles (14)

Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCU

Ileal Predominance in Crohn's Disease Is Associated with Increased Intestinal Surgery and Biological Therapy Use, with Lower Treatment Persistence

T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease

The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3+ Tregs

Real-World Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Retrospective Cohort Study

Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis

Darvadstrocel for complex perianal fistulas in Crohn's disease: A systematic review and meta‐analysis

Real-World Effectiveness and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis

Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence

Long-term impact of early medical prevention of postoperative recurrence on second intestinal resections in patients with Crohn's Disease. Data from the ENEIDA registry

T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease

The Role of IgE in Crohn's Disease by Impairing the Capacity of Plasmacytoid Dendritic Cells to Generate FOXP3<SUP>+</SUP> Tregs

Time-trends in the management of postoperative Crohn's Disease and its impact on long-term surgical recurrence. Data from the ENEIDA registry

Use of FK-adalimumab biosimilar (MSB 11022) in context of biologic switch in Inflammatory Bowel Diseases: 6 months data of the real-world IDEA study

Collaborators (11)

Alba Angelina

Javier Pérez Gisbert

Cristina Benito-Villalvilla

ALEJANDRO HERNANDEZ CAMBA

Inmaculada Alonso Abreu

Luis Bujanda

Beatriz Pereira

Angel Ponferrada

Laura Ramos López

FRANCISCO RODRIGUEZ MORANTA

Leticia Martín-Cruz

Make your next move.